P. Maincent

发表

Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.

P. Couvreur, P. Maincent, R. Le Verge, 1986, Journal of pharmaceutical sciences.

The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker

J. Atkinson, P. Maincent, M. Guerret, 1991, Pharmaceutical Research.

Role of gold nanoparticles capping density on stability and surface reactivity to design drug delivery platforms.

R. Schneider, J. Tournebize, A. Sapin-Minet, 2012, ACS applied materials & interfaces.

Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease.

Y. Kawashima, H. Takeuchi, H. Yamamoto, 2001, The Journal of pharmacology and experimental therapeutics.

Testosterone undecanoate – increase of oral bioavailability by nanostructured lipid carriers (NLC)

Rainer H. Müller, Cornelia M. Keck, Philippe Maincent, 2013 .

Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement

R. Müller, P. Maincent, C. Keck, 2011, Drug development and industrial pharmacy.

Polymer nanocomposite particles of S-nitrosoglutathione: A suitable formulation for protection and sustained oral delivery.

A. Sapin-Minet, P. Maincent, Xianming Hu, 2015, International journal of pharmaceutics.

Low Molecular Weight Heparin-Loaded Polymeric Nanoparticles: Formulation, Characterization, and Release Characteristics

V. Babak, T. Lecompte, P. Maincent, 2002, Drug development and industrial pharmacy.

Preparation and characterization of ethylcellulose microspheres containing 5-fluorouracil.

P. Maincent, M. Hoffman, C. Zinutti, 1994, Journal of microencapsulation.

Drug delivery by polymeric nanoparticles induces autophagy in macrophages.

A. L. Le Faou, B. Mograbi, B. Rihn, 2012, International journal of pharmaceutics.

A comparative biopharmaceutical study of fresh and ageing tolbutamide-polyethyleneglycols solid dispersions

M. Alonso, P. Maincent, J. L. Vila-jato, 1988 .

Preparation and characterization of nanoparticles containing an antihypertensive agent.

Y. I. Kim, P. Maincent, M. Hoffman, 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[Counterfeit and Falsified Drugs: an Overview].

P. Maincent, N. Gambier, V. Gibaja, 2015, Therapie.

Cytotoxicity assessment of heparin nanoparticles in NR8383 macrophages.

R. Duval, B. Rihn, M. Bottin, 2010, International journal of pharmaceutics.

Influence of polymers on the bioavailability of microencapsulated celecoxib

J. Kristl, P. Maincent, N. Ubrich, 2007, Journal of microencapsulation.

Understanding the Thermodynamic Mechanisms Leading to the Binding of Albumin to Lipid Nanocapsules.

A. Sapin-Minet, A. Boudier, P. Maincent, 2020, Langmuir : the ACS journal of surfaces and colloids.

Hydrocortisone delivery to healthy and inflamed eyes using a micellar polysorbate 80 solution or albumin nanoparticles

J. Kreuter, P. Maincent, P. Thouvenot, 1994 .

Influence of different physicochemical conditions on the release of indium oxine from nanocapsules.

P. Maincent, P. Thouvenot, M. Hoffman, 1998, Journal of biomedical materials research.

Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery.

P. Maincent, M. Hoffman, L. Marchal-Heussler, 1993, Pharmaceutical research.

Poly(ε-Caprolactone) Nanocapsules in Carteolol Ophthalmic Delivery

P. Maincent, M. Hoffman, L. Marchal-Heussler, 1993, Pharmaceutical Research.

Enhanced cellular uptake of a glutathione selective fluorogenic probe encapsulated in nanoparticles

J. Lulek, A. Lamprecht, P. Leroy, 2006, Nanotechnology.

How the composition and manufacturing parameters affect insulin release from polymeric nanoparticles

P. Maincent, A. Sapin, T. Sadoun, 2015 .

Food-inspired innovations to improve the stability of active pharmaceutical ingredients.

J. Vigneron, I. Clarot, A. Boudier, 2022, International journal of pharmaceutics.

Design of rolipram-loaded nanoparticles: comparison of two preparation methods.

Y. Kawashima, H. Takeuchi, H. Yamamoto, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Long-term oral administration of aluminum in mice. Aluminum distribution in tissues and effects on calcium metabolism.

P. Maincent, P. Thouvenot, L. Anghileri, 1994, Annals of clinical and laboratory science.

Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats.

P. Maincent, C. Damgé, N. Ubrich, 2007, Journal of controlled release : official journal of the Controlled Release Society.

Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification–solvent evaporation

J. Benoit, V. Babak, P. Maincent, 2003 .

Lipid nanoparticles with a solid matrix (SLN, NLC, LDC) for oral drug delivery.

P. Maincent, M. Muchow, R. Muller, 2008, Drug development and industrial pharmacy.

Antiglaucomatous activity of betaxolol chlorhydrate sorbed onto different isobutylcyanoacrylate nanoparticle preparations

P. Couvreur, P. Maincent, J. Spittler, 1990 .

Bovine mastitis and intramammary drug delivery: review and perspectives.

P. Maincent, V. Kaltsatos, P. Gruet, 2001, Advanced drug delivery reviews.

In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in Rabbits

T. Lecompte, P. Maincent, M. Marchand-Arvier, 2002, Circulation.

In vivo behaviour of low molecular weight iron complexes

P. Maincent, J. Robert, A. Córdova Martínez, 1991, European Journal of Drug Metabolism and Pharmacokinetics.

From the pharmaceutical to the clinical: the case for effervescent paracetamol in pain management. A narrative review

C. Dubray, P. Maincent, Jean-Yves Milon, 2021, Current medical research and opinion.

Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits.

P. Maincent, M. Marchand-Arvier, M. Hoffman, 2002, Journal of pharmaceutical sciences.

Preparation and Characterization of Heparin-Loaded Polymeric Microparticles

P. Maincent, M. Marchand-Arvier, M. Hoffman, 2002, Drug development and industrial pharmacy.

Preparation and In Vitro Evaluation of Heparin-Loaded Polymeric Nanoparticles

P. Maincent, M. Marchand-Arvier, M. Hoffman, 2001, Drug delivery.

Influence of polymers ratio on insulin-loaded nanoparticles based on poly-ε-caprolactone and Eudragit® RS for oral administration

P. Maincent, A. Sapin, C. Damgé, 2009, Drug delivery.

Albumin as a carrier for NO delivery: preparation, physicochemical characterization, and interaction with gold nanoparticles

P. Leroy, A. Boudier, P. Maincent, 2016, Drug development and industrial pharmacy.

Time lasting S-nitrosoglutathione polymeric nanoparticles delay cellular protein S-nitrosation.

R. Diab, A. Sapin-Minet, P. Maincent, 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Simple spectrophotocolorimetric method for quantitative determination of gold in nanoparticles.

R. Schneider, J. Tournebize, A. Sapin-Minet, 2011, Talanta.

Rapid quantitative determination of the sulphate groups of dextran sulphate

P. Maincent, J. Bessière, E. Benoit, 1995 .

Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats

P. Couvreur, J. Kreuter, P. Maincent, 1992, Pharmaceutical Research.

Gold Nanoparticles Grafted by Reduced Glutathione With Thiol Function Preservation

R. Schneider, I. Clarot, P. Leroy, 2016 .

Effects of albumin and adenosine phosphates on iron transfer from ferric lactate

P. Maincent, J. Escanero, A. Córdova-Martínez, 2008, Biological Trace Element Research.

Increase in the vascular residence time of propranolol-loaded nanoparticles coated with heparin.

J. Barré, A. Lamprecht, P. Maincent, 2008, Journal of nanoscience and nanotechnology.

[Value of the new drug carriers in ophthalmology: liposomes and nanoparticles].

P. Maincent, M. Hoffman, L. Marchal-Heussler, 1990, Journal francais d'ophtalmologie.

FK506 Microparticles Mitigate Experimental Colitis with Minor Renal Calcineurin Suppression

Y. Kawashima, H. Takeuchi, A. Lamprecht, 2005, Pharmaceutical Research.

Influence of the casting solvent on the physico-chemical properties of 5-fluorouracil loaded microspheres

J. Benoit, P. Maincent, M. Hoffman, 1996 .

The role of ATP as a mediator in the action of iron complexes on cellular calcium homeostasis

P. Maincent, P. Thouvenot, Alfredo Córdova Martínez, 1994, Biological Trace Element Research.

Low molecular weight heparin nanoparticles: mucoadhesion and behaviour in Caco-2 cells

A. Lamprecht, D. Neumann, P. Maincent, 2006 .

Pellets for oral administration of low-molecular-weight heparin

T. Lecompte, P. Maincent, A. Sapin, 2009, Drug development and industrial pharmacy.

Self-aggregation of cationically modified poly(ε-caprolactone)2-co-poly(ethylene glycol) copolymers: Effect of cationic grafting ligand and poly(ε-caprolactone) chain length.

Shirui Mao, A. Sapin-Minet, P. Maincent, 2017, Materials science & engineering. C, Materials for biological applications.

Low molecular weight heparin loaded pH-sensitive microparticles.

A. Lamprecht, P. Maincent, N. Ubrich, 2007, International journal of pharmaceutics.

Simple and Sensitive HPLC Method with Fluorescence Detection for the Measurement of Ibuprofen in Rat Plasma: Application to a Long-Lasting Dosage Form

P. Leroy, P. Maincent, A. Sapin, 2008 .

Nickel II elimination and autoradiographic distribution in normal and nickel-sensitized guinea pigs

P. Maincent, M. Jacqué, J. Mougeolle, 1988 .

Comparison of tolbutamide β-cyclodextrin inclusion compounds and solid dispersions: Physicochemical characteristics and dissolution studies

M. Huffman, P. Maincent, F. Kedzierewicz, 1990 .

Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin

Francisco Veiga, F. Veiga, P. Maincent, 1996 .

Influence of the Preparation Method on the Physicochemical Properties of Tolbutamide/Cyclodextrin Binary Systems

Philippe Maincent, Francisco Veiga, F. Veiga, 2001, Drug development and industrial pharmacy.

A 3 year stability study of tolbutamide solid dispersions and β-cyclodextrin complex

P. Maincent, F. Villieras, M. Hoffman, 1995 .

Bioavailability study of tolbutamide β-cyclodextrin inclusion compounds, solid dispersions and bulk powder

Philippe Maincent, P. Maincent, M. Hoffman, 1993 .

Crystallinity and dissolution rate of tolbutamide solid dispersions prepared by the melt method.

P. Maincent, J. Mcginity, J W McGinity, 1984, Journal of pharmaceutical sciences.

The preparation and evaluation of poly(ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug

A. Lamprecht, R. Bodmeier, P. Maincent, 2000 .

In situ gelling nasal inserts for influenza vaccine delivery

J. Haensler, Marie-Clotilde Bernard, R. Bodmeier, 2010, Drug development and industrial pharmacy.

Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles.

R. Bodmeier, P. Maincent, M. Hoffman, 2005, International journal of pharmaceutics.

Effect of the formulation on the in-vitro release of propranolol from gellan beads.

C. Lombry, P. Maincent, M. Hoffman, 1999, International journal of pharmaceutics.

Preparation and characterization of propranolol hydrochloride nanoparticles: a comparative study.

P. Maincent, M. Hoffman, N. Ubrich, 2004, Journal of controlled release : official journal of the Controlled Release Society.

Evaluation of peroral silicone dosage forms in humans by gamma-scintigraphy.

P. Maincent, P. Thouvenot, M. Hoffman, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Properties of in situ gelling nasal inserts containing estradiol/methyl β-cyclodextrin

R. Bodmeier, P. Maincent, C. Damgé, 2004 .

Investigation of cationized triblock and diblock poly(ε-caprolactone)-co-poly(ethylene glycol) copolymers for oral delivery of enoxaparin: In vitro approach.

Shirui Mao, A. Sapin-Minet, P. Maincent, 2017, Acta biomaterialia.

Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide).

V. Préat, P. Maincent, C. François, 1996, Biomaterials.

Polymeric Nanoparticles for Increasing Oral Bioavailability of Curcumin

A. Sapin-Minet, P. Maincent, F. Oyarzun-Ampuero, 2018, Antioxidants.

Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique.

A. Lamprecht, C. Lehr, P. Maincent, 2000, International journal of pharmaceutics.

Biodegradable monodispersed nanoparticles prepared by pressure homogenization-emulsification.

A. Lamprecht, C. Lehr, P. Maincent, 1999, International journal of pharmaceutics.

Selective in vitro removal of anti-A antibodies by adsorption on encapsulated erythrocyte-ghosts.

P. Maincent, C. Vigneron, N. Ubrich, 1997, Journal of biomedical materials research.

Engineered Nanoparticulate Drug Delivery Systems: The Next Frontier for Oral Administration?

H. Fessi, R. Diab, P. Maincent, 2012, The AAPS Journal.

Impact of bulk and surface properties of some biocompatible hydrophobic polymers on the stability of methylene chloride-in-water mini-emulsions used to prepare nanoparticles by emulsification-solvent evaporation.

F. Boury, V. Babak, F. Baros, 2007, Colloids and surfaces. B, Biointerfaces.

Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

R. Müller, P. Maincent, M. Muchow, 2008, Drug development and industrial pharmacy.

Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.

Ying Fan, Wen Wu, Jinqiang Zhang, 2018, Critical reviews in therapeutic drug carrier systems.

PLGA in situ implants formed by phase inversion: critical physicochemical parameters to modulate drug release.

A. Boudier, P. Maincent, A. Sapin, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Poly(epsilon-caprolactone)/eudragit nanoparticles for oral delivery of aspart-insulin in the treatment of diabetes.

P. Maincent, C. Damgé, N. Ubrich, 2010, Journal of pharmaceutical sciences.

In Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke

A. Boudier, P. Maincent, F. Dupuis, 2015, PloS one.

Immunoadsorption of Alloantibodies onto Erythroid Membrane Antigens Encapsulated into Polymeric Microparticles

A. Lamprecht, V. Jouan-Hureaux, T. Lecompte, 2007, Pharmaceutical Research.

Non-degradable microparticles containing a hydrophilic and/or a lipophilic drug: preparation, characterization and drug release modeling.

J. Siepmann, A. Lamprecht, R. Bodmeier, 2003, Journal of controlled release : official journal of the Controlled Release Society.

Omega-3 fatty acids-loaded lipid nanoparticles for patient-convenient oral bioavailability enhancement.

R. Müller, P. Maincent, M. Muchow, 2009, Pharmazie.

Preparation and in vitro–in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles

J. Lulek, A. Sapin-Minet, P. Leroy, 2009, Journal of microencapsulation.

Formulation characterization and in vitro evaluation of acacia gum-calcium alginate beads for oral drug delivery systems: Acacia Gum-Calcium Alginate Beads for Oral Drug Delivery

M. S. El-shall, A. Benaboura, R. Barillé, 2018 .

Applicability of Dielectric Measurements to the Adsorption of Beta Blockers onto a Pharmaceutical Grade Ion-exchange Resin

P. Maincent, J. Bessière, L. Marchal-Heussler, 2000, Pharmaceutical Research.

Oral administration of a microencapsulated low-molecular-weight heparin to rabbits: Anti-Xa and anti-IIa profiles

T. Lecompte, P. Maincent, A. Sapin, 2010, Thrombosis and Haemostasis.

Encapsulation of low molecular weight heparins: influence on the anti-Xa/anti-IIa ratio.

T. Lecompte, P. Maincent, M. Rabišková, 2009, Journal of controlled release : official journal of the Controlled Release Society.

Granules in the improvement of oral heparin bioavailability.

T. Lecompte, P. Maincent, M. Rabišková, 2009, International journal of pharmaceutics.

Nanoparticle strategies for the oral delivery of insulin

P. Maincent, C. Reis, C. Damgé, 2008, Expert opinion on drug delivery.

LR12-peptide quantitation in whole blood by RP-HPLC and intrinsic fluorescence detection: Validation and pharmacokinetic study.

M. Kouach, J. Goossens, I. Clarot, 2017, Biomedical chromatography : BMC.

LR 12 ‐ peptide quantitation in whole blood by RP ‐ HPLC and intrinsic fluorescence detection : Validation and pharmacokinetic study

M. Kouach, I. Clarot, P. Leroy, 2017 .

Preparation of silicone microspheres by emulsion polymerization: application to the encapsulation of a hydrophilic drug.

P. Maincent, M. Hoffman, F. Kedzierewicz, 1998, Journal of microencapsulation.

Cardiotoxicity of parenterally administered iron complexes.

P. Maincent, P. Thouvenot, L. Anghileri, 1995, Arzneimittel-Forschung.

On the mechanism of soft tissue calcification induced by complexed iron.

P. Maincent, A. Córdova-Martínez, L. Anghileri, 1993, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.

R. Bodmeier, P. Maincent, H. Kranz, 2000, Journal of pharmaceutical sciences.

Polymer nanocomposites enhance S-nitrosoglutathione intestinal absorption and promote the formation of releasable nitric oxide stores in rat aorta.

A. Sapin-Minet, P. Maincent, Xianming Hu, 2016, Nanomedicine : nanotechnology, biology, and medicine.

Determination of heparin in aqueous solutions

B. Demoré, P. Maincent, M. Hoffman, 1998, Journal of clinical pharmacy and therapeutics.

Development of enoxaparin sodium polymeric microparticles for colon-specific delivery

I. Tomuță, L. Vlase, A. Sapin-Minet, 2015, Clujul medical.

Oral bioavailability of a low molecular weight heparin using a polymeric delivery system.

A. Lamprecht, T. Lecompte, P. Maincent, 2006, Journal of controlled release : official journal of the Controlled Release Society.

Impact of gold nanoparticle coating on redox homeostasis.

G. Bartosz, J. Tournebize, A. Sapin-Minet, 2012, International journal of pharmaceutics.

Formulation development of drug nanocrystals and nanoparticles for dermal delivery

P. Maincent, 2018 .

Reduction of the in vivo burst release of insulin-loaded microparticles

P. Leroy, P. Maincent, A. Sapin, 2015 .

THE REGULATORY ENVIRONMENT : THE CHALLENGES FOR LIPID-BASED FORMULATION

P. Maincent, 2007 .

Comparison of the biodistribution in mice of 111indium oxine encapsulated into poly(lactic-co-glycolic)-D,L-85/15 and poly(epsilon caprolactone) nanocapsules.

P. Maincent, P. Thouvenot, M. Hoffman, 1999, Journal of pharmaceutical sciences.

Elaboration of Sterically Stabilized Liposomes for S-Nitrosoglutathione Targeting to Macrophages.

A. Elaissari, B. Rihn, P. Leroy, 2016, Journal of biomedical nanotechnology.

Are in situ formulations the keys for the therapeutic future of S-nitrosothiols?

J. Six, P. Leroy, A. Boudier, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Evaluation of subcutaneous forms in the improvement of pharmacokinetic profile of warfarin.

T. Lecompte, P. Maincent, A. Sapin, 2012, International journal of pharmaceutics.

[The interchangeability of excipient formulations and the eventual consequences].

P. Maincent, 1999, Therapie.

Doxorubicin-loaded glycyrrhetinic acid modified recombinant human serum albumin nanoparticles for targeting liver tumor chemotherapy.

A. Sapin-Minet, P. Maincent, Xianming Hu, 2015, Molecular pharmaceutics.

One-week in vivo sustained release of a peptide formulated into in situ forming implants.

I. Clarot, P. Leroy, A. Boudier, 2017, International journal of pharmaceutics.

Microporous microparticles designed as stable immunoadsorbents.

P. Maincent, C. Vigneron, N. Ubrich, 1998, Biotechnology and bioengineering.

Stealth nanoparticles coated with heparin as peptide or protein carriers

J. Barré, C. Passirani, T. Lecompte, 2009, Journal of drug targeting.

In vitro and in vivo evaluation of carbamazepine-loaded enteric microparticles.

R. Bodmeier, P. Maincent, W. Dong, 2007, International journal of pharmaceutics.

Simple and sensitive HPLC method with fluorescence detection for the measurement of ibuprofen in rat plasma: application to a long-lasting dosage form.

P. Leroy, P. Maincent, A. Sapin, 2008, Drug development and industrial pharmacy.

Formulation of Insulin-Loaded Polymeric Nanoparticles Using Response Surface Methodology

P. Maincent, N Ubrich, M Hoffman, 2005, Drug development and industrial pharmacy.

Polymeric Dispersions as Drug Carriers

P. Maincent, R. Bodmeier, 1998 .

Zeta-potential and morphology of electrospun nano- and microfibers from biopolymers and their blends used as scaffolds in tissue engineering

C. Vaquette, V. Babak, F. Baros, 2008 .

Low molecular weight heparin gels, based on nanoparticles, for topical delivery.

J. Grossiord, A. Sapin-Minet, P. Maincent, 2012, International journal of pharmaceutics.

Formulation and statistical optimization of dextran-calcium alginate beads for controlled oral drug delivery systems

A. Benaboura, R. Barillé, A. Sapin-Minet, 2018, Advance Pharmaceutical Journal.

Oral low molecular weight heparin delivery by microparticles from complex coacervation.

Alf Lamprecht, Philippe Maincent, A. Lamprecht, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

APPLICABILITY OF DIELECTRIC MEASUREMENTS IN THE FIELD OF PHARMACEUTICAL FORMULATION

P. Maincent, J. Bessière, E. Benoit, 1996 .

Are in situ formulations the keys for the therapeutic future of S-nitrosothiols?

J. Six, P. Leroy, A. Boudier, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Microencapsulation of Low Molecular Weight Heparin into Polymeric Particles Designed with Biodegradable and Nonbiodegradable Polycationic Polymers

A. Lamprecht, P. Maincent, M. Hoffman, 2003, Drug delivery.

Effect of the microencapsulation of nanoparticles on the reduction of burst release.

A. Lamprecht, P. Maincent, A. Sapin, 2007, International journal of pharmaceutics.

Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles

P. Maincent, C. Loira-Pastoriza, A. Haroun, 2014, Drug development and industrial pharmacy.

Adsorption of Beta-Blockers onto Polyisobutylcyanoacrylate Nanoparticles Measured by Depletion and Dielectric Methods

P. Maincent, J. Bessière, E. Benoit, 1994, Pharmaceutical Research.